Trials / Unknown
UnknownNCT04967001
68Ga-PSMA PET in the Prostate Cancer
Efficacy of 68Ga PSMA PET in the Diagnosis of Lymph Node Metastasis in Patients With Prostate Cancer: a Single Center Prospective Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- Male
- Age
- 40 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Efficacy of 68Ga PSMA PET / CT in the diagnosis of lymph node metastasis in patients with prostate cancer: a single center prospective randomized controlled trial. To identify and compare the diagnostic efficacy of 68Ga-PSMA PET/CT and mpMRI for lymph nodes in patients with newly diagnosed prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | PSMA PET | 68Ga-PSMA PET |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2024-06-01
- Completion
- 2024-12-31
- First posted
- 2021-07-19
- Last updated
- 2024-01-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04967001. Inclusion in this directory is not an endorsement.